156 related articles for article (PubMed ID: 35900644)
1. High serum levels of L-carnitine and citric acid negatively correlated with alkaline phosphatase are detectable in Koreans before gastric cancer onset.
Han Y; Yoo HJ; Jee SH; Lee JH
Metabolomics; 2022 Jul; 18(8):62. PubMed ID: 35900644
[TBL] [Abstract][Full Text] [Related]
2. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
3. High-resolution metabolomics study revealing l-homocysteine sulfinic acid, cysteic acid, and carnitine as novel biomarkers for high acute myocardial infarction risk.
Khan A; Choi Y; Back JH; Lee S; Jee SH; Park YH
Metabolism; 2020 Mar; 104():154051. PubMed ID: 31874143
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer.
Huang S; Guo Y; Li ZW; Shui G; Tian H; Li BW; Kadeerhan G; Li ZX; Li X; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
JAMA Netw Open; 2021 Jun; 4(6):e2114186. PubMed ID: 34156450
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics study identified bile acids as potential biomarkers for gastric cancer: A case control study.
Pan C; Deng D; Wei T; Wu Z; Zhang B; Yuan Q; Liang G; Liu Y; Yin P
Front Endocrinol (Lausanne); 2022; 13():1039786. PubMed ID: 36465663
[TBL] [Abstract][Full Text] [Related]
6. Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk.
Li B; Shu X; Jiang H; Shi C; Qi L; Zhu L; Zhou J; Tang M; Hu A
Metabolomics; 2023 Aug; 19(8):73. PubMed ID: 37561286
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
8. S100A9, GIF and AAT as potential combinatorial biomarkers in gastric cancer diagnosis and prognosis.
Wu W; Juan WC; Liang CR; Yeoh KG; So J; Chung MC
Proteomics Clin Appl; 2012 Apr; 6(3-4):152-62. PubMed ID: 22532451
[TBL] [Abstract][Full Text] [Related]
9. Metabolite biomarker discovery for human gastric cancer using dried blood spot mass spectrometry metabolomic approach.
Wu X; Ao H; Gao H; Zhu Z
Sci Rep; 2022 Aug; 12(1):14632. PubMed ID: 36030300
[TBL] [Abstract][Full Text] [Related]
10. Analysis of metabolites and metabolic pathways in breast cancer in a Korean prospective cohort: the Korean Cancer Prevention Study-II.
Yoo HJ; Kim M; Kim M; Kang M; Jung KJ; Hwang SM; Jee SH; Lee JH
Metabolomics; 2018 Jun; 14(6):85. PubMed ID: 30830383
[TBL] [Abstract][Full Text] [Related]
11. Identification of the urine and serum metabolomics signature of gout.
Huang Y; Xiao M; Ou J; Lv Q; Wei Q; Chen Z; Wu J; Tu L; Jiang Y; Zhang X; Qi J; Qiu M; Cao S; Gu J
Rheumatology (Oxford); 2020 Oct; 59(10):2960-2969. PubMed ID: 32134107
[TBL] [Abstract][Full Text] [Related]
12. Metabolic changes preceding bladder cancer occurrence among Korean men: a nested case-control study from the KCPS-II cohort.
Han Y; Kim U; Jung KJ; Lee JY; Lee K; Shin SY; Kimm H; Jee SH
Cancer Metab; 2023 Dec; 11(1):23. PubMed ID: 38053135
[TBL] [Abstract][Full Text] [Related]
13. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA.
Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263
[TBL] [Abstract][Full Text] [Related]
14. Potential metabolomic biomarkers for reliable diagnosis of Behcet's disease using gas chromatography/ time-of-flight-mass spectrometry.
Ahn JK; Kim J; Hwang J; Song J; Kim KH; Cha HS
Joint Bone Spine; 2018 May; 85(3):337-343. PubMed ID: 28549946
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive biomarkers for early diagnosis of pancreatic cancer risk: metabolite genomewide association study based on the KCPS-II cohort.
Han Y; Jung KJ; Kim U; Jeon CI; Lee K; Jee SH
J Transl Med; 2023 Dec; 21(1):878. PubMed ID: 38049855
[TBL] [Abstract][Full Text] [Related]
16. Development of a mass spectrometry-based pseudotargeted metabolomics strategy to analyze hormone-stimulated gastric cancer cells.
Li J; Wang Q; Zheng Y; Zhou P; Xu X; Liu X; Zhao L; Liu H
J Pharm Biomed Anal; 2020 Feb; 180():113041. PubMed ID: 31855724
[TBL] [Abstract][Full Text] [Related]
17. Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers.
Song G; Wang L; Tang J; Li H; Pang S; Li Y; Liu L; Hu J
Metabolomics; 2023 Apr; 19(4):36. PubMed ID: 37014438
[TBL] [Abstract][Full Text] [Related]
18. Discovery of metabolomic biomarkers for discriminating platinum-sensitive and platinum-resistant ovarian cancer by using GC-MS.
Eroglu EC; Tunug S; Geckil OF; Gulec UK; Vardar MA; Paydas S
Eur J Mass Spectrom (Chichester); 2021 Dec; 27(6):235-248. PubMed ID: 34806450
[TBL] [Abstract][Full Text] [Related]
19. Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile.
Jing F; Hu X; Cao Y; Xu M; Wang Y; Jing Y; Hu X; Gao Y; Zhu Z
IUBMB Life; 2018 Jun; 70(6):553-562. PubMed ID: 29626382
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
